Context: Patients with advanced cancer are at increased risk for multiple hospitalizations and often have considerable needs postdischarge. Interventions to address patients' needs after transitioning home are lacking.
Objectives: We sought to demonstrate the feasibility and acceptability of a postdischarge intervention for this population.
Purpose: To assess the efficacy, tolerability, and pharmacokinetics of ecteinascidin 743 (ET-743) in patients with advanced gastrointestinal stromal tumors (GISTs).
Patients And Methods: The study was confined to adult patients with radiographically measurable GISTs. ET-743 was administered as a 24-hour continuous i.